These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7910130)

  • 1. Prolonged paralysis in intensive care unit patients after the use of neuromuscular blocking agents: a review of the literature.
    Watling SM; Dasta JF
    Crit Care Med; 1994 May; 22(5):884-93. PubMed ID: 7910130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of implementation of neuromuscular blockade monitoring standards in a surgical intensive care unit.
    Frankel H; Jeng J; Tilly E; St Andre A; Champion H
    Am Surg; 1996 Jun; 62(6):503-6. PubMed ID: 8651538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged neuromuscular blockade following vecuronium infusion.
    Lagasse RS; Katz RI; Petersen M; Jacobson MJ; Poppers PJ
    J Clin Anesth; 1990; 2(4):269-71. PubMed ID: 1975190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged neuromuscular blockade after long-term infusion of vecuronium bromide in the intensive care unit.
    Partridge BL; Abrams JH; Bazemore C; Rubin R
    Crit Care Med; 1990 Oct; 18(10):1177-9. PubMed ID: 1976485
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids.
    Barohn RJ; Jackson CE; Rogers SJ; Ridings LW; McVey AL
    Muscle Nerve; 1994 Jun; 17(6):647-54. PubMed ID: 7910951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent paralysis in critically ill patients after long-term administration of vecuronium.
    Segredo V; Caldwell JE; Matthay MA; Sharma ML; Gruenke LD; Miller RD
    N Engl J Med; 1992 Aug; 327(8):524-8. PubMed ID: 1353252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective analysis of long-term use of nondepolarizing neuromuscular blocking agents in the intensive care unit, and guidelines for drug selection.
    Clarens DM; Kelly KJ; Gilliland SS; Kohls PK; Nahum A; Vance-Bryan K
    Pharmacotherapy; 1993; 13(6):647-55. PubMed ID: 7905621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged neuromuscular blockade in two critically ill patients treated with atracurium.
    Hoey LL; Joslin SM; Nahum A; Vance-Bryan K
    Pharmacotherapy; 1995; 15(2):254-9. PubMed ID: 7624274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent paralysis after prolonged use of atracurium in the absence of corticosteroids.
    Rubio ER; Seelig CB
    South Med J; 1996 Jun; 89(6):624-6. PubMed ID: 8638206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of neuromuscular blocking drugs in intensive care practice.
    Elliot JM; Bion JF
    Acta Anaesthesiol Scand Suppl; 1995; 106():70-82. PubMed ID: 8533552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients.
    Rudis MI; Sikora CA; Angus E; Peterson E; Popovich J; Hyzy R; Zarowitz BJ
    Crit Care Med; 1997 Apr; 25(4):575-83. PubMed ID: 9142020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Muscle relaxants in the ICU].
    Schneider G
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 May; 44(5):358-64; quiz 366, 379. PubMed ID: 19440945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action.
    Debaene B; Plaud B; Dilly MP; Donati F
    Anesthesiology; 2003 May; 98(5):1042-8. PubMed ID: 12717123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients.
    Prielipp RC; Coursin DB; Scuderi PE; Bowton DL; Ford SR; Cardenas VJ; Vender J; Howard D; Casale EJ; Murray MJ
    Anesth Analg; 1995 Jul; 81(1):3-12. PubMed ID: 7598277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous-infusion neuromuscular blocking agents in critically ill neonates and children.
    Johnson PN; Miller J; Gormley AK
    Pharmacotherapy; 2011 Jun; 31(6):609-20. PubMed ID: 21923445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged neuromuscular blockade in a horse following concomitant use of vecuronium and atracurium.
    Gurney M; Mosing M
    Vet Anaesth Analg; 2012 Jan; 39(1):119-20. PubMed ID: 22118190
    [No Abstract]   [Full Text] [Related]  

  • 18. Randomised controlled trial comparing cisatracurium and vecuronium infusions in a paediatric intensive care unit.
    Burmester M; Mok Q
    Intensive Care Med; 2005 May; 31(5):686-92. PubMed ID: 15815895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged paralysis after neuromuscular blockade.
    Gooch JL
    J Toxicol Clin Toxicol; 1995; 33(5):419-26. PubMed ID: 7650766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nondepolarizing neuromuscular blocking drugs in the intensive care unit: a clinical review.
    Reeves ST; Turcasso NM
    South Med J; 1997 Aug; 90(8):769-74. PubMed ID: 9258301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.